Regnante Keith (CIK 1682068) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-20). Recent activity: Sell KROS (4,739 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-20 | Keros Therapeutics, Inc. (KROS) | CHIEF FINANCIAL OFFICER | Sell | 4,739 | $77,483 |
来源：SEC Form 4 申报文件 · 截至 2026-02-20